Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 158774 |
| Drug Identification Number | 02465833 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | Piperacillin and Tazobactam for Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 4.5G 36G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 200 mL |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-01-10 |
| Estimated end date | 2022-04-30 |
| Actual end date | 2022-04-30 |
| Shortage status | Resolved |
| Updated date | 2022-05-02 |
| Company comments | On 100% allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-05-02 | French | Compare |
| v3 | 2022-05-02 | English | Compare |
| v2 | 2022-04-13 | French | Compare |
| v1 | 2022-04-13 | English | Compare |
Showing 1 to 4 of 4